NCT00389207View on ClinicalTrials.gov

Nevirapine or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir in Human Immunodeficiency Virus (HIV)-1-infected Treatment Naive Adults

PHASE3CompletedINTERVENTIONAL
Enrollment

576

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

February 28, 2011

Conditions
HIV Infections
Interventions
DRUG

nevirapine bid

nevirapine twice daily

DRUG

nevirapine qd

nevirapine once daily

DRUG

atazanavir

atazanavir once daily

Trial Locations (68)

Unknown

1100.1470.54004 Boehringer Ingelheim Investigational Site, Capital Federal

1100.1470.54002 Boehringer Ingelheim Investigational Site, Córdoba

1100.1470.54003 Boehringer Ingelheim Investigational Site, Mar del Plata

1100.1470.54001 Boehringer Ingelheim Investigational Site, Rosario

1100.1470.49001 Boehringer Ingelheim Investigational Site, Berlin

1100.1470.49002 Boehringer Ingelheim Investigational Site, Berlin

1100.1470.49003 Boehringer Ingelheim Investigational Site, Bochum

1100.1470.49018 Boehringer Ingelheim Investigational Site, Bonn

1100.1470.49014 Boehringer Ingelheim Investigational Site, Düsseldorf

1100.1470.49008 Boehringer Ingelheim Investigational Site, Erlangen

1100.1470.49035 Boehringer Ingelheim Investigational Site, Frankfurt

1100.1470.49036 Boehringer Ingelheim Investigational Site, Frankfurt am Main

1100.1470.49033 Boehringer Ingelheim Investigational Site, Freiburg/Breisgau

1100.1470.49016 Boehringer Ingelheim Investigational Site, Hamburg

1100.1470.49031 Boehringer Ingelheim Investigational Site, Hamburg

1100.1470.49037 Boehringer Ingelheim Investigational Site, Hamburg

1100.1470.49020 Boehringer Ingelheim Investigational Site, Hanover

1100.1470.49038 Boehringer Ingelheim Investigational Site, Magdeburg

1100.1470.49034 Boehringer Ingelheim Investigational Site, München

1100.1470.49000 Boehringer Ingelheim Investigational Site, Ulm

1100.1470.49032 Boehringer Ingelheim Investigational Site, Würzburg

1100.1470.39001 Boehringer Ingelheim Investigational Site, Bergamo

1100.1470.39003 Boehringer Ingelheim Investigational Site, Bologna

1100.1470.39012 Ospedale Sant'Anna, Como

1100.1470.39006 Boehringer Ingelheim Investigational Site, Ferrara

1100.1470.39010 Boehringer Ingelheim Investigational Site, Lecco

1100.1470.39004 Boehringer Ingelheim Investigational Site, Torino

1100.1470.39009 Boehringer Ingelheim Investigational Site, Torrette Di Ancona

1100.1470.39007 Boehringer Ingelheim Investigational Site, Varese

1100.1470.55006 Boehringer Ingelheim Investigational Site, Aguascalientes

1100.1470.55004 Boehringer Ingelheim Investigational Site, Col Obregón

1100.1470.55008 Boehringer Ingelheim Investigational Site, Col. Los Filtros, San Luis Potosí

1100.1470.55001 Boehringer Ingelheim Investigational Site, Col. Toriello Guerra

1100.1470.55007 Boehringer Ingelheim Investigational Site, Guadalajara Jal.

1100.1470.55003 Boehringer Ingelheim Investigational Site, Tlalpan-México D,F

1100.1470.48003 Boehringer Ingelheim Investigational Site, Bydgoszcz

1100.1470.48001 Boehringer Ingelheim Investigational Site, Chorzów

1100.1470.48002 Boehringer Ingelheim Investigational Site, Szczecin

1100.1470.48004 Boehringer Ingelheim Investigational Site, Warsaw

1100.1470.35102 Boehringer Ingelheim Investigational Site, Cascais

1100.1470.35101 Boehringer Ingelheim Investigational Site, Lisbon

1100.1470.35103 Boehringer Ingelheim Investigational Site, Porto

1100.1470.40001 Boehringer Ingelheim Investigational Site, Bucharest

1100.1470.40002 Boehringer Ingelheim Investigational Site, Bucharest

1100.1470.34013 Boehringer Ingelheim Investigational Site, Alcalá de Henares (Madrid)

1100.1470.34008 Boehringer Ingelheim Investigational Site, Badalona

1100.1470.34002 Boehringer Ingelheim Investigational Site, Barcelona

1100.1470.34003 Boehringer Ingelheim Investigational Site, Barcelona

1100.1470.34004 Boehringer Ingelheim Investigational Site, Donostia / San Sebastian

1100.1470.34009 Boehringer Ingelheim Investigational Site, L'Hospitalet de Llobregat

1100.1470.34010 Boehringer Ingelheim Investigational Site, Madrid

1100.1470.34012 Boehringer Ingelheim Investigational Site, Madrid

1100.1470.34014 Boehringer Ingelheim Investigational Site, Madrid

1100.1470.34015 Boehringer Ingelheim Investigational Site, Madrid

1100.1470.34019 Boehringer Ingelheim Investigational Site, Málaga

1100.1470.34007 Boehringer Ingelheim Investigational Site, Sabadell (Barcelona)

1100.1470.34006 Boehringer Ingelheim Investigational Site, Santa Cruz de Tenerife

1100.1470.34011 Boehringer Ingelheim Investigational Site, Vigo

1100.1470.41004 Boehringer Ingelheim Investigational Site, Bern

1100.1470.41001 Boehringer Ingelheim Investigational Site, Lugano

1100.1470.41003 Boehringer Ingelheim Investigational Site, Sankt Gallen

1100.1470.41002 Boehringer Ingelheim Investigational Site, Zurich

1100.1470.44004 Boehringer Ingelheim Investigational Site, Birmingham

1100.1470.44001 Boehringer Ingelheim Investigational Site, London

1100.1470.44002 Boehringer Ingelheim Investigational Site, London

1100.1470.44005 Boehringer Ingelheim Investigational Site, London

1100.1470.44006 Boehringer Ingelheim Investigational Site, London

1100.1470.44003 Boehringer Ingelheim Investigational Site, Manchester

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY